HCW Biologics Inc.
HCWB
$2.46
-$0.05-1.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.22M | 3.47M | 719.20K | -4.55M | -1.93M |
| Total Depreciation and Amortization | 127.10K | 142.00K | 156.90K | 173.90K | 291.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.96M | -4.16M | -3.87M | 1.35M | -1.60M |
| Change in Net Operating Assets | -835.20K | -1.03M | -361.70K | -213.40K | -45.00K |
| Cash from Operations | -3.97M | -1.58M | -3.36M | -3.24M | -3.28M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 150.00K |
| Total Debt Repaid | -32.80K | -259.30K | -32.80K | -31.40K | -30.90K |
| Issuance of Common Stock | 5.50M | -- | 742.40K | 1.99M | 5.30M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.99M | 1.11M | 3.50M | -63.50K | -802.60K |
| Cash from Financing | 3.48M | 851.60K | 4.21M | 1.90M | 4.61M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -487.60K | -723.60K | 855.60K | -1.34M | 1.33M |